Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Sep 1;366(Pt 2):531–539. doi: 10.1042/BJ20020046

Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.

Nica M Borradaile 1, Linda E de Dreu 1, Lisa J Wilcox 1, Jane Y Edwards 1, Murray W Huff 1
PMCID: PMC1222800  PMID: 12030847

Abstract

Diets containing the soya-derived phytoestrogens, genistein and daidzein, decrease plasma cholesterol in humans and experimental animals. The mechanisms responsible for the hypocholesterolaemic effects of these isoflavones are unknown. The present study was conducted to determine if genistein and daidzein regulate hepatocyte cholesterol metabolism and apolipoprotein (apo) B secretion in cultured human hepatoma (HepG2) cells. ApoB secretion was decreased dose-dependently by up to 63% and 71% by genistein and daidzein (100 microM; P<0.0001) respectively. In contrast, no effect on apoAI secretion was observed. Cellular cholesterol synthesis was inhibited 41% by genistein (100 microM; P<0.005) and 18% by daidzein (100 microM; P<0.05), which was associated with significant increases in 3-hydroxy-3-methylglutaryl-CoA reductase mRNA. Cellular cholesterol esterification was decreased 56% by genistein (100 microM; P<0.04) and 29% by daidzein (100 microM; P<0.04); however, mRNA levels for acyl-CoA:cholesterol acyltransferase (ACAT) 1 and ACAT2 were unaffected. At 100 microM, both isoflavones equally inhibited the activities of both forms of ACAT in cells transfected with either ACAT1 or ACAT2. Genistein (100 microM) and daidzein (100 microM) significantly decreased the activity of microsomal triacylglycerol transfer protein (MTP) by 30% and 24% respectively, and significantly decreased MTP mRNA levels by 35% and 55%. Both isoflavones increased low-density lipoprotein (LDL)-receptor mRNA levels by 3- to 6-fold (100 microM; P<0.03) and significantly increased the binding, uptake and degradation of (125)I-labelled LDL, suggesting that enhanced reuptake of newly secreted apoB-containing lipoproteins contributed to the net decrease in apoB secretion. These results indicate that genistein and daidzein inhibit hepatocyte apoB secretion through several mechanisms, including inhibition of cholesterol synthesis and esterification, inhibition of MTP activity and expression and increased expression of the LDL-receptor.

Full Text

The Full Text of this article is available as a PDF (166.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adeli K., Sinkevitch C. Secretion of apolipoprotein B in serum-free cultures of human hepatoma cell line, HepG2. FEBS Lett. 1990 Apr 24;263(2):345–348. doi: 10.1016/0014-5793(90)81410-p. [DOI] [PubMed] [Google Scholar]
  2. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
  3. Anderson J. W., Johnstone B. M., Cook-Newell M. E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995 Aug 3;333(5):276–282. doi: 10.1056/NEJM199508033330502. [DOI] [PubMed] [Google Scholar]
  4. Anderson R. A., Joyce C., Davis M., Reagan J. W., Clark M., Shelness G. S., Rudel L. L. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem. 1998 Oct 9;273(41):26747–26754. doi: 10.1074/jbc.273.41.26747. [DOI] [PubMed] [Google Scholar]
  5. Angelin B., Olivecrona H., Reihnér E., Rudling M., Ståhlberg D., Eriksson M., Ewerth S., Henriksson P., Einarsson K. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology. 1992 Nov;103(5):1657–1663. doi: 10.1016/0016-5085(92)91192-7. [DOI] [PubMed] [Google Scholar]
  6. Anthony M. S., Clarkson T. B., Bullock B. C., Wagner J. D. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2524–2531. doi: 10.1161/01.atv.17.11.2524. [DOI] [PubMed] [Google Scholar]
  7. Anthony M. S., Clarkson T. B., Hughes C. L., Jr, Morgan T. M., Burke G. L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996 Jan;126(1):43–50. doi: 10.1093/jn/126.1.43. [DOI] [PubMed] [Google Scholar]
  8. Baum J. A., Teng H., Erdman J. W., Jr, Weigel R. M., Klein B. P., Persky V. W., Freels S., Surya P., Bakhit R. M., Ramos E. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998 Sep;68(3):545–551. doi: 10.1093/ajcn/68.3.545. [DOI] [PubMed] [Google Scholar]
  9. Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34–47. doi: 10.1126/science.3513311. [DOI] [PubMed] [Google Scholar]
  10. Burnett J. R., Wilcox L. J., Telford D. E., Kleinstiver S. J., Barrett P. H., Newton R. S., Huff M. W. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Endocrinology. 1999 Nov;140(11):5293–5302. doi: 10.1210/endo.140.11.7150. [DOI] [PubMed] [Google Scholar]
  11. Carroll K. K., Kurowska E. M. Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr. 1995 Mar;125(3 Suppl):594S–597S. doi: 10.1093/jn/125.3_Suppl.594S. [DOI] [PubMed] [Google Scholar]
  12. Cianflone K. M., Yasruel Z., Rodriguez M. A., Vas D., Sniderman A. D. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990 Nov;31(11):2045–2055. [PubMed] [Google Scholar]
  13. Clarkson T. B., Anthony M. S., Williams J. K., Honoré E. K., Cline J. M. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc Soc Exp Biol Med. 1998 Mar;217(3):365–368. doi: 10.3181/00379727-217-44246. [DOI] [PubMed] [Google Scholar]
  14. Croston G. E., Milan L. B., Marschke K. B., Reichman M., Briggs M. R. Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology. 1997 Sep;138(9):3779–3786. doi: 10.1210/endo.138.9.5404. [DOI] [PubMed] [Google Scholar]
  15. Crouse J. R., 3rd, Morgan T., Terry J. G., Ellis J., Vitolins M., Burke G. L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999 Sep 27;159(17):2070–2076. doi: 10.1001/archinte.159.17.2070. [DOI] [PubMed] [Google Scholar]
  16. Davis R. A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim Biophys Acta. 1999 Aug 25;1440(1):1–31. doi: 10.1016/s1388-1981(99)00083-9. [DOI] [PubMed] [Google Scholar]
  17. Erickson S. K., Jaeckle S., Lear S. R., Brady S. M., Havel R. J. Regulation of hepatic cholesterol and lipoprotein metabolism in ethinyl estradiol-treated rats. J Lipid Res. 1989 Nov;30(11):1763–1771. [PubMed] [Google Scholar]
  18. Evans A. J., Sawyez C. G., Wolfe B. M., Huff M. W. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. J Biol Chem. 1992 May 25;267(15):10743–10751. [PubMed] [Google Scholar]
  19. Ginsberg H. N. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells. Clin Exp Pharmacol Physiol. 1997 May;24(5):A29–A32. doi: 10.1111/j.1440-1681.1997.tb03051.x. [DOI] [PubMed] [Google Scholar]
  20. Gooderham M. H., Adlercreutz H., Ojala S. T., Wähälä K., Holub B. J. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr. 1996 Aug;126(8):2000–2006. doi: 10.1093/jn/126.8.2000. [DOI] [PubMed] [Google Scholar]
  21. Haghpassand M., Wilder D., Moberly J. B. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2). J Lipid Res. 1996 Jul;37(7):1468–1480. [PubMed] [Google Scholar]
  22. Hodgson J. M., Puddey I. B., Beilin L. J., Mori T. A., Croft K. D. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr. 1998 Apr;128(4):728–732. doi: 10.1093/jn/128.4.728. [DOI] [PubMed] [Google Scholar]
  23. Huff M. W., Carroll K. K. Effects of dietary protein on turnover, oxidation, and absorption of cholesterol, and on steroid excretion in rabbits. J Lipid Res. 1980 Jul;21(5):546–548. [PubMed] [Google Scholar]
  24. Huff M. W., Giovannetti P. M., Wolfe B. M. Turnover of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men. Am J Clin Nutr. 1984 Jun;39(6):888–897. doi: 10.1093/ajcn/39.6.888. [DOI] [PubMed] [Google Scholar]
  25. Huff M. W., Hamilton R. M., Carroll K. K. Plasma cholesterol levels in rabbits fed low fat, cholesterol-free, semipurified diets: effects of dietary proteins, protein hydrolysates and amino acid mixtures. Atherosclerosis. 1977 Oct;28(2):187–195. doi: 10.1016/0021-9150(77)90156-3. [DOI] [PubMed] [Google Scholar]
  26. Huff M. W., Roberts D. C., Carroll K. K. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis. 1982 Feb;41(2-3):327–336. doi: 10.1016/0021-9150(82)90197-6. [DOI] [PubMed] [Google Scholar]
  27. Jamil H., Dickson J. K., Jr, Chu C. H., Lago M. W., Rinehart J. K., Biller S. A., Gregg R. E., Wetterau J. R. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport. J Biol Chem. 1995 Mar 24;270(12):6549–6554. doi: 10.1074/jbc.270.12.6549. [DOI] [PubMed] [Google Scholar]
  28. Khosla P., Samman S., Carroll K. K., Huff M. W. Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein. Biochim Biophys Acta. 1989 Apr 3;1002(2):157–163. doi: 10.1016/0005-2760(89)90282-8. [DOI] [PubMed] [Google Scholar]
  29. Kirk E. A., Sutherland P., Wang S. A., Chait A., LeBoeuf R. C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr. 1998 Jun;128(6):954–959. doi: 10.1093/jn/128.6.954. [DOI] [PubMed] [Google Scholar]
  30. Kovanen P. T., Brown M. S., Goldstein J. L. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem. 1979 Nov 25;254(22):11367–11373. [PubMed] [Google Scholar]
  31. Lin M. C., Gordon D., Wetterau J. R. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res. 1995 May;36(5):1073–1081. [PubMed] [Google Scholar]
  32. Lovati M. R., Manzoni C., Canavesi A., Sirtori M., Vaccarino V., Marchi M., Gaddi G., Sirtori C. R. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest. 1987 Nov;80(5):1498–1502. doi: 10.1172/JCI113232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Markiewicz L., Garey J., Adlercreutz H., Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol. 1993 May;45(5):399–405. doi: 10.1016/0960-0760(93)90009-l. [DOI] [PubMed] [Google Scholar]
  34. Merz-Demlow B. E., Duncan A. M., Wangen K. E., Xu X., Carr T. P., Phipps W. R., Kurzer M. S. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000 Jun;71(6):1462–1469. doi: 10.1093/ajcn/71.6.1462. [DOI] [PubMed] [Google Scholar]
  35. Nestel P. J., Yamashita T., Sasahara T., Pomeroy S., Dart A., Komesaroff P., Owen A., Abbey M. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3392–3398. doi: 10.1161/01.atv.17.12.3392. [DOI] [PubMed] [Google Scholar]
  37. Potter S. M. Soy protein and serum lipids. Curr Opin Lipidol. 1996 Aug;7(4):260–264. doi: 10.1097/00041433-199608000-00013. [DOI] [PubMed] [Google Scholar]
  38. Pullinger C. R., North J. D., Teng B. B., Rifici V. A., Ronhild de Brito A. E., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989 Jul;30(7):1065–1077. [PubMed] [Google Scholar]
  39. Rudel L. L., Lee R. G., Cockman T. L. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr Opin Lipidol. 2001 Apr;12(2):121–127. doi: 10.1097/00041433-200104000-00005. [DOI] [PubMed] [Google Scholar]
  40. Samman S., Khosla P., Carroll K. K. Effects of dietary casein and soy protein on metabolism of radiolabelled low density apolipoprotein B in rabbits. Lipids. 1989 Mar;24(3):169–172. doi: 10.1007/BF02535230. [DOI] [PubMed] [Google Scholar]
  41. Setchell K. D., Brown N. M., Desai P., Zimmer-Nechemias L., Wolfe B. E., Brashear W. T., Kirschner A. S., Cassidy A., Heubi J. E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001 Apr;131(4 Suppl):1362S–1375S. doi: 10.1093/jn/131.4.1362S. [DOI] [PubMed] [Google Scholar]
  42. Shelness G. S., Sellers J. A. Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol. 2001 Apr;12(2):151–157. doi: 10.1097/00041433-200104000-00008. [DOI] [PubMed] [Google Scholar]
  43. Sirtori C. R., Lovati M. R. Soy proteins and cardiovascular disease. Curr Atheroscler Rep. 2001 Jan;3(1):47–53. doi: 10.1007/s11883-001-0010-2. [DOI] [PubMed] [Google Scholar]
  44. St Clair R. W. Estrogens and atherosclerosis: phytoestrogens and selective estrogen receptor modulators. Curr Opin Lipidol. 1998 Oct;9(5):457–463. doi: 10.1097/00041433-199810000-00010. [DOI] [PubMed] [Google Scholar]
  45. Tam S. P., Archer T. K., Deeley R. G. Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone. Proc Natl Acad Sci U S A. 1986 May;83(10):3111–3115. doi: 10.1073/pnas.83.10.3111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vega G. L., Denke M. A., Grundy S. M. Metabolic basis of primary hypercholesterolemia. Circulation. 1991 Jul;84(1):118–128. doi: 10.1161/01.cir.84.1.118. [DOI] [PubMed] [Google Scholar]
  47. Vitolins M. Z., Anthony M., Burke G. L. Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidol. 2001 Aug;12(4):433–437. doi: 10.1097/00041433-200108000-00010. [DOI] [PubMed] [Google Scholar]
  48. Wangen K. E., Duncan A. M., Xu X., Kurzer M. S. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr. 2001 Feb;73(2):225–231. doi: 10.1093/ajcn/73.2.225. [DOI] [PubMed] [Google Scholar]
  49. Washburn S., Burke G. L., Morgan T., Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999 Spring;6(1):7–13. [PubMed] [Google Scholar]
  50. Wetterau J. R., Gregg R. E., Harrity T. W., Arbeeny C., Cap M., Connolly F., Chu C. H., George R. J., Gordon D. A., Jamil H. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science. 1998 Oct 23;282(5389):751–754. doi: 10.1126/science.282.5389.751. [DOI] [PubMed] [Google Scholar]
  51. Whitman S. C., Argmann C. A., Sawyez C. G., Miller D. B., Hegele R. A., Huff M. W. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. J Lipid Res. 1999 Jun;40(6):1017–1028. [PubMed] [Google Scholar]
  52. Wilcox L. J., Barrett P. H., Huff M. W. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. J Lipid Res. 1999 Jun;40(6):1078–1089. [PubMed] [Google Scholar]
  53. Wilcox L. J., Barrett P. H., Newton R. S., Huff M. W. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):939–949. doi: 10.1161/01.atv.19.4.939. [DOI] [PubMed] [Google Scholar]
  54. Wilcox L. J., Borradaile N. M., de Dreu L. E., Huff M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May;42(5):725–734. [PubMed] [Google Scholar]
  55. Yao Z. M., Vance D. E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem. 1988 Feb 25;263(6):2998–3004. [PubMed] [Google Scholar]
  56. Yao Z., Tran K., McLeod R. S. Intracellular degradation of newly synthesized apolipoprotein B. J Lipid Res. 1997 Oct;38(10):1937–1953. [PubMed] [Google Scholar]
  57. Yotsumoto H., Yanagita T., Yamamoto K., Ogawa Y., Cha J. Y., Mori Y. Inhibitory effects of oren-gedoku-to and its components on cholesteryl ester synthesis in cultured human hepatocyte HepG2 cells: evidence from the cultured HepG2 cells and in vitro assay of ACAT. Planta Med. 1997 Apr;63(2):141–145. doi: 10.1055/s-2006-957631. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES